{"id":"W4224311311","doi":"10.2217/fon-2022-0045","title":"A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ <i>PIK3CA</i> -mutated breast cancer","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Trastuzumab; Medicine; Fulvestrant; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001995535,0.001123032,0.001527103,0.000376172,0.0003159419,0.000796053,0.0007182765,0.001061459,0.006000008],"category_scores_gemma":[0.001054963,0.0003403176,0.001172549,0.0002917328,0.0006030641,0.0005150963,0.0003118118,0.002376448,0.001155135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005228945,"about_ca_system_score_gemma":0.001418259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005890423,"about_ca_topic_score_gemma":0.001460314,"domain_scores_codex":[0.9995798,0.0002538618,0.00001811641,0.00004390772,0.00003967883,0.00006463651],"domain_scores_gemma":[0.9993495,0.0001737799,0.0001278404,0.00004852248,0.00003443269,0.0002659331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8962536,0.0272401,0.001526902,0.0006512636,0.0006214425,0.00009664636,0.00006168643,0.001247954,0.006960901,0.0004893282,0.003697145,0.06115292],"study_design_scores_gemma":[0.8753964,0.1193761,0.001756541,0.00003639279,0.0001785474,0.00006161508,0.00001875251,0.0005915401,0.0006940167,0.0001890982,0.001691143,0.000009646808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742171,0.004542431,0.001291985,0.001291127,0.0006172962,0.007855824,0.002457338,0.0002196514,0.007507359],"genre_scores_gemma":[0.9589289,0.004435697,0.005068134,0.003087183,0.0005878846,0.01098853,0.004958808,0.00004946613,0.0118953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006000008,"threshold_uncertainty_score":0.02007204,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03373686270539864,"score_gpt":0.405549785522902,"score_spread":0.3718129228175033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}